Analyst Research: Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

8.70USD
20 May 2013
Price Change (% chg)

$-0.15 (-1.69%)
Prev Close
$8.85
Open
$8.86
Day's High
$8.96
Day's Low
$8.52
Volume
98,056
Avg. Vol
76,268
52-wk High
$9.65
52-wk Low
$3.73

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - REPLIGEN CORPORATION (RGEN-O) 20 May 2013 Thomson Reuters Stock Report 12 25.00
REPLIGEN CORP (RGEN) 12-months forecast 17 May 2013 Pechala's Reports 1 15.00
Repligen Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 17 May 2013 Reuters Investment Profile 12 20.00
Repligen Corp 11 May 2013 S&P Capital IQ Quantitative Report 6 69.00
Validea Guru Analysis Report for RGEN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. 10 May 2013 Validea 0 12.00
RGEN: Due Diligence Review: Forensic Earnings and Valuation 8 May 2013 New Constructs, LLC 13 25.00
RGEN.OQ - Event Transcript of Repligen Corp conference call, May 02, 2013 / 9:00AM ET 2 May 2013 Thomson Reuters StreetEvents 9 75.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of REPLIGEN CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 25 Apr 2013 Jefferson Research 11 20.00
ValuEngine Detailed Valuation Report for RGEN 31 Mar 2013 ValuEngine, Inc. 11 127.00
 

People

Name Age Since Current Position

Karen Dawes

 60 2011 Independent Chairman of the Board

Alexander Rich

 87 2011 Independent Chairperson Emeritus of the Board

Walter Herlihy

 60 1996 President, Chief Executive Officer, Director

Jonathan Lieber

 40 2012 Chief Financial Officer, Treasurer, Principal Financial Officer

Michael Hall

 50 2011 Chief Medical Officer and Senior Vice President - Clinical and Regulatory Affairs
» More People

Repligen Corp News

» More RGEN.OQ News
Search Stocks